Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 3 of 37 Results 51 to 75 of 923
Time from initial referral for specialist care until biologic therapy prescription for patients with severe uncontrolled asthma
REG Summit 2025Contributions to Conferences: PostersThe compAIR study:: The carbon footprint of asthma inhalers before and after initiation of Fostair MART
REG Summit 2025Contributions to Conferences: PostersEUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR
Frontiers in Allergy, vol. 5, 1531788Contributions to Journals: ArticlesCharacteristics of Patients with Asthma or Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and Switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone/Formoterol/Glycopyrronium (BDP/FF/G)
AAAAI / WAO Joint Congress 2025, pp. AB239Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.jaci.2024.12.734
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD
Advances in Therapy, vol. 42, pp. 375–394Contributions to Journals: ArticlesSystemic corticosteroid dose-response effects in asthma: an observational cohort study
ERJ Open Research, vol. 11, no. 1, 00172-2024Contributions to Journals: LettersRe “Inhaled Corticosteroid Particle Size and Risk of Hospitalization Rue to Exacerbations and All-Cause Mortality in Patients With Chronic Obstructive Respiratory Disease. A Nationwide Cohort Study”. Heerfordt et al [Letter]
International journal of chronic obstructive pulmonary disease , vol. 20, pp. 243—244Contributions to Journals: LettersAsthma Characteristics and Patient-Reported Outcomes in Patients With Atopic Dermatitis in the RAPID Registry of Dupilumab Use in a Real-World Setting
ISPOR Europe, S525Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.jval.2024.10.3347
Characteristics of Patients With Asthma and History of Coexisting Allergic Rhinitis Initiating Dupilumab in Real-World Clinical Practice: The RAPID Registry Study
ISPOR 2024, pp. S575Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.jval.2024.10.3579
A randomised, double-blind placebo controlled trial of the effectiveness of the beta-blocker bisoprolol in preventing exacerbations of chronic obstructive pulmonary disease
Health Technology AssessmentContributions to Journals: ArticlesPreserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary Disease.
Pragmatic and Observational Research, vol. 2024, no. 15, pp. 221-232Contributions to Journals: ArticlesSystematic corticosteroid increases healthcare costs in Australian patients with asthma
TSANZSRS 2025Contributions to Conferences: AbstractsExcess SABA prescribing in respiratory patients and social deprivation in general practice: A study of 4 million patients
ISPOR 2024, pp. S40Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.jval.2024.10.214
At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK)
BTS Winter Meeting 2024Contributions to Conferences: AbstractsUse and acceptability of an asthma diagnosis clinical decision support system for primary care clinicians: an observational mixed methods study
npj Primary Care Respiratory Medicine, vol. 34, 40Contributions to Journals: ArticlesDo asthma patients prescribed a GLP1 have improved asthma and weight loss outcomes?
ISPOR 2024Contributions to Conferences: AbstractsDo asthma patients prescribed a GLP1 have improved asthma outcomes?
ASPR 2024Contributions to Conferences: AbstractsCOPD Treatment Pathways In Patients Initiating Dual Bronchodilators Or Triple Inhaled Therapies In A Real-World Setting
Contributions to Journals: Conference Articles- [ONLINE] DOI: https://doi.org/10.1136/thorax-2024-BTSabstracts.461
S108 At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK)
Thorax, vol. 79, no. Suppl. 2, A76Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1136/thorax-2024-BTSabstracts.113
Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study
npj Primary Care Respiratory Medicine, vol. 34, no. 1, 34Contributions to Journals: ArticlesCharacteristics of long-term oral corticosteroid users stratified by blood eosinophil count in the International Severe Asthma Registry
European Respiratory Society (ERS) Congress 2024, PA439Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2024.PA439
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry
Journal of Asthma and Allergy, vol. 2024, no. 17, pp. 1055-1069Contributions to Journals: ArticlesImproving the Transparency and Replicability of Consensus Methods: Respiratory Medicine as a Case Example
Pragmatic and Observational Research, vol. 2024, no. 15, pp. 201-207Contributions to Journals: ArticlesExacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations
European Respiratory Journal, vol. 64, no. 4, 2302240Contributions to Journals: ArticlesReal-world biologics response and super-response in the International Severe Asthma Registry cohort
Allergy, vol. 79, no. 10, pp. 2700-2716Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/all.16178
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/dd20c59c-12e0-40f6-82bf-2d64d3050d55/download